These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 11881166

  • 21. [The role of steroids in the treatment of COPD].
    Reynard C.
    Rev Med Suisse; 2007 Feb 21; 3(99):457-8, 460-1. PubMed ID: 17424796
    [Abstract] [Full Text] [Related]

  • 22. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
    Antoniu SA.
    Biomarkers; 2010 Mar 21; 15(2):97-103. PubMed ID: 19929747
    [Abstract] [Full Text] [Related]

  • 23. [Inhaled steroids in COPD. Do they modify the disease?].
    Welte T, Gillissen A.
    MMW Fortschr Med; 2002 Apr 11; 144(15):39-41. PubMed ID: 12004448
    [Abstract] [Full Text] [Related]

  • 24. [Clinical efficacy of inhaled corticosteroids in COPD].
    Kamoi H, Yoshikawa T, Hirata K.
    Nihon Rinsho; 2007 Apr 11; 65(4):696-701. PubMed ID: 17419390
    [Abstract] [Full Text] [Related]

  • 25. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 11; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 26. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.
    Eur J Gen Pract; 2007 Oct 11; 13(2):89-91. PubMed ID: 17534745
    [Abstract] [Full Text] [Related]

  • 27. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review.
    Restrepo RD.
    Respir Care; 2009 Aug 11; 54(8):1058-81. PubMed ID: 19650947
    [Abstract] [Full Text] [Related]

  • 28. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A.
    Respir Med; 2005 Jul 11; 99(7):816-24. PubMed ID: 15939243
    [Abstract] [Full Text] [Related]

  • 29. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug 11; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 30. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
    Black PN, McDonald CF.
    Postgrad Med J; 2009 Mar 11; 85(1001):141-7. PubMed ID: 19351641
    [Abstract] [Full Text] [Related]

  • 31. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct 11; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 32. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M, Bosse S, Oltmanns U, Schumacher A, Witt C.
    Respir Med; 2005 Nov 11; 99(11):1418-24. PubMed ID: 15894479
    [Abstract] [Full Text] [Related]

  • 33. COPD management. Part I. Strategies for managing the burden of established COPD.
    Jenkins C.
    Int J Tuberc Lung Dis; 2008 Jun 11; 12(6):586-94. PubMed ID: 18492322
    [Abstract] [Full Text] [Related]

  • 34. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Bonay M, Bancal C, Crestani B.
    Drug Saf; 2002 Jun 11; 25(1):57-71. PubMed ID: 11820912
    [Abstract] [Full Text] [Related]

  • 35. The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease.
    Raghavan N, Guenette JA, O'Donnell DE.
    Ther Adv Respir Dis; 2011 Aug 11; 5(4):245-54. PubMed ID: 21357348
    [Abstract] [Full Text] [Related]

  • 36. [Treatment with inhalation corticosteroids: useful or useless in chronic obstructive pulmonary disease (COPD)?].
    van Schayck CP.
    Ned Tijdschr Geneeskd; 1999 Apr 10; 143(15):778-80. PubMed ID: 10347639
    [Abstract] [Full Text] [Related]

  • 37. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.
    Am J Respir Crit Care Med; 2003 Dec 15; 168(12):1488-94. PubMed ID: 14525798
    [Abstract] [Full Text] [Related]

  • 38. How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?
    Antón E.
    Expert Rev Respir Med; 2013 Apr 15; 7(2 Suppl):25-32. PubMed ID: 23551021
    [Abstract] [Full Text] [Related]

  • 39. [Individually-tailored treatment of chronic obstructive pulmonary disease: a proposed change].
    Miravitlles M.
    Arch Bronconeumol; 2009 Apr 15; 45 Suppl 5():27-34. PubMed ID: 20116759
    [Abstract] [Full Text] [Related]

  • 40. [Safety of inhaled corticosteroids in COPD].
    Esteban C, Aburto M.
    Arch Bronconeumol; 2010 Apr 15; 46 Suppl 4():28-35. PubMed ID: 20850024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.